Garrett Vygantas, M.D.
With over 15 years of clinical, commercial and capital formation experience, Garrett is a physician entrepreneur who co-leads the healthcare practice at OSF Healthcare Ventures, the VC fund of the 13-hospital health system called OSF based in the Mid West. OSF deploys capital in medtech, digital health, diagnostics and services companies that positively impact the provider ecosystem.
Prior to OSF, Garrett led HCIT and digital health investments at Jump Capital. Previously, Garrett founded NewBridge Pharmaceuticals, a specialty pharma company that commercializes medical products in the emerging markets. He raised over $65M in VC financing and created $470M in nominal value. Before NewBridge, Garrett was a director with Burrill Ventures where he invested in biotech, pharma, HCIT and medtech. He is the founder of Ceratotech, a bioengineering company working to save endangered species from poached extinction. Formerly at Genentech, he worked on the launch of Lucentis™, a $4B biologic treatment for retinal diseases.
Garrett earned his medical degree and MBA from Georgetown University and completed his residency at the University of Pennsylvania. He is a Kauffman Fellow and serves on a variety of corporate and non-profit boards.